Tenet Healthcare Corp THC
We take great care to ensure that the data presented and summarized in this overview for TENET HEALTHCARE CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding THC
View all-
Black Rock Inc. New York, NY9.88MShares$1.91 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.01MShares$1.74 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.37MShares$1.42 Billion0.16% of portfolio
-
Boston Partners Boston, MA3.15MShares$607 Million0.7% of portfolio
-
State Street Corp Boston, MA2.73MShares$527 Million0.02% of portfolio
-
Glenview Capital Management, LLC New York, NY2.32MShares$448 Million10.63% of portfolio
-
Invesco Ltd. Atlanta, GA2.13MShares$410 Million0.07% of portfolio
-
Aqr Capital Management LLC Greenwich, CT1.88MShares$362 Million0.25% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.84MShares$354 Million0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA1.78MShares$343 Million0.02% of portfolio
Latest Institutional Activity in THC
Top Purchases
Top Sells
About THC
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.
Insider Transactions at THC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 06
2025
|
R. Scott Ramsey Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
13,322
-85.56%
|
$2,731,010
$205.63 P/Share
|
|
Nov 05
2025
|
Tammy Romo |
SELL
Open market or private sale
|
Direct |
645
-1.82%
|
$132,225
$205.2 P/Share
|
|
Nov 04
2025
|
Tammy Romo |
SELL
Open market or private sale
|
Direct |
11,756
-12.55%
|
$2,398,224
$204.48 P/Share
|
|
Nov 03
2025
|
Tammy Romo |
SELL
Open market or private sale
|
Direct |
15,099
-8.66%
|
$3,034,899
$201.31 P/Share
|
|
Oct 29
2025
|
J Robert Kerrey |
SELL
Bona fide gift
|
Direct |
971
-4.34%
|
-
|
|
Oct 29
2025
|
Richard W Fisher |
SELL
Open market or private sale
|
Direct |
2,500
-22.14%
|
$520,000
$208.43 P/Share
|
|
Sep 10
2025
|
Saumya Sutaria CEO |
SELL
Open market or private sale
|
Direct |
78,762
-9.13%
|
$15,043,542
$191.09 P/Share
|
|
Aug 29
2025
|
Saumya Sutaria CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
81,261
-7.96%
|
$14,952,024
$184.33 P/Share
|
|
Aug 29
2025
|
Saumya Sutaria CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
53,341
+9.16%
|
-
|
|
Aug 28
2025
|
Christopher S. Lynch |
SELL
Open market or private sale
|
Direct |
8
-0.06%
|
$1,464
$183.44 P/Share
|
|
Aug 20
2025
|
Lisa Y Foo EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
8,000
-27.7%
|
$1,432,000
$179.53 P/Share
|
|
Aug 19
2025
|
Christopher S. Lynch |
SELL
Open market or private sale
|
Direct |
3,952
-24.23%
|
$695,552
$176.39 P/Share
|
|
Aug 13
2025
|
Saumya Sutaria CEO |
BUY
Grant, award, or other acquisition
|
Direct |
106,682
+18.33%
|
-
|
|
Aug 13
2025
|
Sun Park EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,813
-37.68%
|
$1,507,023
$171.87 P/Share
|
|
Aug 13
2025
|
Sun Park EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,707
+46.96%
|
-
|
|
Jun 05
2025
|
Paola M Arbour EVP, Chief Information Officer |
SELL
Open market or private sale
|
Direct |
7,738
-27.79%
|
$1,338,674
$173.0 P/Share
|
|
Jun 05
2025
|
Richard W Fisher |
SELL
Open market or private sale
|
Direct |
836
-6.89%
|
$144,628
$173.16 P/Share
|
|
May 29
2025
|
James L Bierman |
SELL
Open market or private sale
|
Direct |
4,613
-11.57%
|
$784,210
$170.0 P/Share
|
|
May 27
2025
|
James L Bierman |
SELL
Open market or private sale
|
Direct |
1,551
-3.74%
|
$255,915
$165.72 P/Share
|
|
May 27
2025
|
Richard W Fisher |
SELL
Open market or private sale
|
Direct |
3,077
-20.24%
|
$507,705
$165.72 P/Share
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 214K shares |
|---|---|
| Grant, award, or other acquisition | 290K shares |
| Sale (or disposition) back to the issuer | 4.05K shares |
|---|---|
| Open market or private sale | 200K shares |
| Bona fide gift | 17K shares |
| Payment of exercise price or tax liability | 235K shares |